{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T10:55:39Z","timestamp":1792839339664,"version":"4.5.0"},"reference-count":217,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jhep.2015.10.019","type":"journal-article","created":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T00:35:09Z","timestamp":1446510909000},"page":"717-735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":264,"title":["Management of the critically ill patient with cirrhosis: A multidisciplinary perspective"],"prefix":"10.1016","volume":"64","author":[{"given":"Mitra K.","family":"Nadim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Kellum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Levitsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline G.","family":"O\u2019Leary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine J.","family":"Karvellas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmohan S.","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Jalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen H.","family":"Caldwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Francoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guadalupe","family":"Garcia-Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Gin\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Ison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravindra L.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mulligan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody C.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Pomfret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Senzolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randolph H.","family":"Steadman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram M.","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri S.","family":"Genyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2015.10.019_b0005","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/hep.1840070124","article-title":"Compensated cirrhosis: natural history and prognostic factors","volume":"7","author":"Gines","year":"1987","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.10.019_b0010","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jhep.2014.01.024","article-title":"Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013","volume":"60","author":"Jalan","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.10.019_b0015","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.jhep.2012.06.026","article-title":"Acute-on chronic liver failure","volume":"57","author":"Jalan","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.10.019_b0020","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1002\/hep.24622","article-title":"Intensive care of the patient with cirrhosis","volume":"54","author":"Olson","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.10.019_b0025","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.jhep.2015.10.019_b0030","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jhep.2013.03.039","article-title":"Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites","volume":"59","author":"Piano","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.10.019_b0035","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1053\/j.gastro.2013.08.051","article-title":"New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection","volume":"145","author":"Wong","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.10.019_b0040","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/gutjnl-2011-301255","article-title":"Acute kidney injury in decompensated cirrhosis","volume":"62","author":"Tsien","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2015.10.019_b0045","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/hep.26687","article-title":"Type-1 hepatorenal syndrome associated with infections in cirrhosis: natural history, outcome of kidney function, and survival","volume":"59","author":"Barreto","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.10.019_b0050","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ki.2014.338","article-title":"Renal dysfunction in cirrhosis is not just a vasomotor nephropathy","volume":"87","author":"Adebayo","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.jhep.2015.10.019_b0055","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMra0809139","article-title":"Renal failure in cirrhosis","volume":"361","author":"Gines","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2015.10.019_b0060","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.gastro.2007.10.055","article-title":"Relationship between activation of the sympathetic nervous system and renal blood flow autoregulation in cirrhosis","volume":"134","author":"Stadlbauer","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.10.019_b0065","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/lt.23384","article-title":"Impact of the etiology of acute kidney injury on outcomes following liver transplantation: acute tubular necrosis versus hepatorenal syndrome","volume":"18","author":"Nadim","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2015.10.019_b0070","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/lt.21367","article-title":"Transplantation: impact of pretransplant renal insufficiency","volume":"14","author":"Bahirwani","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2015.10.019_b0075","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/lt.20445","article-title":"Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation","volume":"11","author":"Campbell","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2015.10.019_b0080","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1111\/j.1600-6143.2006.01526.x","article-title":"Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us?","volume":"6","author":"Gonwa","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2015.10.019_b0085","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/bja\/aeu556","article-title":"Acute kidney injury following orthotopic liver transplantation: incidence, risk factors, and effects on patient and graft outcomes","volume":"114","author":"Hilmi","year":"2015","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jhep.2015.10.019_b0090","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1093\/ndt\/gfr354","article-title":"Pitfalls in assessing renal function in patients with cirrhosis\u2013potential inequity for access to treatment of hepatorenal failure and liver transplantation","volume":"26","author":"Davenport","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jhep.2015.10.019_b0095","doi-asserted-by":"crossref","first-page":"R82","DOI":"10.1186\/cc9004","article-title":"Fluid accumulation, recognition and staging of acute kidney injury in critically-ill patients","volume":"14","author":"Macedo","year":"2010","journal-title":"Crit Care"},{"key":"10.1016\/j.jhep.2015.10.019_b0100","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1097\/CCM.0b013e318228234b","article-title":"Acute kidney injury in patients with acute lung injury: impact of fluid accumulation on classification of acute kidney injury and associated outcomes","volume":"39","author":"Liu","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jhep.2015.10.019_b0105","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2215\/CJN.03400410","article-title":"Comparison of cystatin C and creatinine-based glomerular filtration rate formulas with 51Cr-EDTA clearance in patients with cirrhosis","volume":"6","author":"Xirouchakis","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jhep.2015.10.019_b0110","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/gut.50.1.106","article-title":"Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver","volume":"50","author":"Gerbes","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2015.10.019_b0115","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1002\/hep.26704","article-title":"Glomerular filtration rate equations for liver-kidney transplantation in patients with cirrhosis: validation of current recommendations","volume":"59","author":"Francoz","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.10.019_b0120","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jhep.2009.11.025","article-title":"The evaluation of renal function and disease in patients with cirrhosis","volume":"52","author":"Francoz","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.10.019_b0125","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/lt.20017","article-title":"Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations","volume":"10","author":"Gonwa","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2015.10.019_b0130","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/hep.26556","article-title":"Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis","volume":"59","author":"Mindikoglu","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.10.019_b0135","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/hep.26886","article-title":"Creatinine-versus cystatine C-based equations in assessing the renal function of candidates for liver transplantation with cirrhosis","volume":"59","author":"De Souza","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.10.019_b0140","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2015.10.019_b0145","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2015.10.019_b0150","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1186\/cc11188","article-title":"Hepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group","volume":"16","author":"Nadim","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.jhep.2015.10.019_b0155","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/gut.2010.236133","article-title":"Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis","volume":"60","author":"Wong","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2015.10.019_b0160","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/hep.25735","article-title":"Association of AKI with mortality and complications in hospitalized patients with cirrhosis","volume":"57","author":"Belcher","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.10.019_b0165","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1097\/MCG.0b013e31822e8e12","article-title":"Acute kidney injury network criteria as a predictor of hospital mortality in cirrhotic patients with ascites","volume":"46","author":"de Carvalho","year":"2012","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2015.10.019_b0170","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jhep.2013.04.036","article-title":"A modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis","volume":"59","author":"Fagundes","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.10.019_b0175","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jhep.2014.10.047","article-title":"A cut-off serum creatinine value of 1.5mg\/dl for AKI \u2013 To be or not to be","volume":"62","author":"Wong","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.10.019_b0180","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit Care"},{"key":"10.1016\/j.jhep.2015.10.019_b0185","first-page":"1","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group KDIGO Clinical Practice Guideline for Acute Kidney Injury","author":"KDIGO","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.jhep.2015.10.019_b0190","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jhep.2014.12.029","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites","volume":"62","author":"Angeli","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.10.019_b0195","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1681\/ASN.2014070724","article-title":"Classifying AKI by urine output versus serum creatinine level","volume":"26","author":"Kellum","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jhep.2015.10.019_b0200","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/ki.2011.150","article-title":"Oliguria is an early predictor of higher mortality in critically ill patients","volume":"80","author":"Macedo","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.jhep.2015.10.019_b0205","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/ndt\/gfq332","article-title":"Defining urine output criterion for acute kidney injury in critically ill patients","volume":"26","author":"Macedo","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jhep.2015.10.019_b0210","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/ki.2009.479","article-title":"Commonly used surrogates for baseline renal function affect the classification and prognosis of acute kidney injury","volume":"77","author":"Siew","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.jhep.2015.10.019_b0215","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1093\/ndt\/gfp766","article-title":"A comparison of three methods to estimate baseline creatinine for RIFLE classification","volume":"25","author":"Zavada","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jhep.2015.10.019_b0220","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/ki.2014.293","article-title":"The growth of acute kidney injury: a rising tide or just closer attention to detail?","volume":"87","author":"Siew","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.jhep.2015.10.019_b0225","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/hep.23286","article-title":"Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome","volume":"51","author":"Gluud","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.10.019_b0230","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.2215\/CJN.09430913","article-title":"Urinary biomarkers and progression of AKI in patients with cirrhosis","volume":"9","author":"Belcher","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jhep.2015.10.019_b0235","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.26980","article-title":"Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury","volume":"60","author":"Belcher","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.10.019_b0240","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1007\/s10620-012-2180-x","article-title":"Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis","volume":"57","author":"Verna","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2015.10.019_b0245","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jhep.2012.03.015","article-title":"Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis","volume":"57","author":"Fagundes","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.10.019_b0250","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jhep.2014.02.023","article-title":"Urinary neutrophil gelatinase-associated lipocalin predicts kidney outcome and death in patients with cirrhosis and bacterial infections","volume":"61","author":"Barreto","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.10.019_b0255","doi-asserted-by":"crossref","first-page":"e0128145","DOI":"10.1371\/journal.pone.0128145","article-title":"Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis","volume":"10","author":"Ariza","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2015.10.019_b0260","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/hep.21901","article-title":"Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome","volume":"46","author":"Krag","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.10.019_b0265","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1097\/01.CCM.0000178182.37639.D6","article-title":"Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study","volume":"33","author":"Albanese","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jhep.2015.10.019_b0270","doi-asserted-by":"crossref","first-page":"e107466","DOI":"10.1371\/journal.pone.0107466","article-title":"Terlipressin versus norepinephrine in the treatment of hepatorenal syndrome: a systematic review and meta-analysis","volume":"9","author":"Nassar Junior","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2015.10.019_b0275","first-page":"S245","article-title":"Effect of renal replacement therapy on patients with combined acute renal and fulminant hepatic failure","volume":"41","author":"Davenport","year":"1993","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.jhep.2015.10.019_b0280","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa0902413","article-title":"Intensity of continuous renal-replacement therapy in critically ill patients","volume":"361","author":"Bellomo","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2015.10.019_b0285","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jhep.2014.11.012","article-title":"The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure","volume":"62","author":"Jalan","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.10.019_b0290","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.10.019_b0295","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1097\/00003246-200008000-00007","article-title":"Effects of perfusion pressure on tissue perfusion in septic shock","volume":"28","author":"LeDoux","year":"2000","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jhep.2015.10.019_b0300","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s00134-014-3525-z","article-title":"Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine","volume":"40","author":"Cecconi","year":"2014","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jhep.2015.10.019_b0305","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s00134-002-1206-9","article-title":"A randomised, controlled trial of the pulmonary artery catheter in critically ill patients","volume":"28","author":"Rhodes","year":"2002","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jhep.2015.10.019_b0310","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1056\/NEJMoa062200","article-title":"Comparison of two fluid-management strategies in acute lung injury","volume":"354","author":"Wiedemann","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2015.10.019_b0315","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/01.sla.0000094387.50865.23","article-title":"Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens: a randomized assessor-blinded multicenter trial","volume":"238","author":"Brandstrup","year":"2003","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2015.10.019_b0320","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/0885066608329850","article-title":"Review of a large clinical series: association of cumulative fluid balance on outcome in acute lung injury: a retrospective review of the ARDSnet tidal volume study cohort","volume":"24","author":"Rosenberg","year":"2009","journal-title":"J Intensive Care Med"},{"key":"10.1016\/j.jhep.2015.10.019_b0325","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1378\/chest.97.5.1176","article-title":"Improved survival in ARDS patients associated with a reduction in pulmonary capillary wedge pressure","volume":"97","author":"Humphrey","year":"1990","journal-title":"Chest"},{"key":"10.1016\/j.jhep.2015.10.019_b0330","first-page":"138","article-title":"The abdominal compartment syndrome. Clinical relevance","volume":"68","author":"Aspesi","year":"2002","journal-title":"Minerva Anestesiol"},{"key":"10.1016\/j.jhep.2015.10.019_b0335","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s001340050962","article-title":"Comparison of pulmonary artery and arterial thermodilution cardiac output in critically ill patients","volume":"25","author":"Sakka","year":"1999","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jhep.2015.10.019_b0340","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/cc12526","article-title":"Assessment of volume responsiveness during mechanical ventilation: recent advances","volume":"17","author":"Monnet","year":"2013","journal-title":"Crit Care"},{"key":"10.1016\/j.jhep.2015.10.019_b0345","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1213\/ANE.0b013e31822401b2","article-title":"Evaluation of a new software version of the FloTrac\/Vigileo (version 3.02) and a comparison with previous data in cirrhotic patients undergoing liver transplant surgery","volume":"113","author":"Biancofiore","year":"2011","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jhep.2015.10.019_b0350","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0002-8703(03)00248-5","article-title":"Reliability of reporting left ventricular systolic function by echocardiography: a systematic review of 3 methods","volume":"146","author":"McGowan","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.jhep.2015.10.019_b0355","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1478-3231.2007.01510.x","article-title":"Acid-base disturbances in critically ill patients with cirrhosis","volume":"27","author":"Funk","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2015.10.019_b0360","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jhep.2014.10.012","article-title":"Exploration of skin perfusion in cirrhotic patients with septic shock","volume":"62","author":"Galbois","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.10.019_b0365","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa040232","article-title":"A comparison of albumin and saline for fluid resuscitation in the intensive care unit","volume":"350","author":"Finfer","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2015.10.019_b0370","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMra1208627","article-title":"Resuscitation fluids","volume":"369","author":"Myburgh","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2015.10.019_b0375","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jhep.2014.04.012","article-title":"Human serum albumin, systemic inflammation, and cirrhosis","volume":"61","author":"Arroyo","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.10.019_b0380","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/jhep.2002.35819","article-title":"Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study","volume":"36","author":"Ortega","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.10.019_b0385","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"341","author":"Sort","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2015.10.019_b0390","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0016-5085(96)70068-9","article-title":"Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis","volume":"111","author":"Gines","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.10.019_b0395","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1478-3231.2005.01188.x","article-title":"Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: a randomised controlled pilot trail","volume":"26","author":"Moreau","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2015.10.019_b0400","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1053\/jhep.2003.50169","article-title":"Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites","volume":"37","author":"Sola-Vera","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.10.019_b0405","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jhep.2012.06.013","article-title":"Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study","volume":"57","author":"Guevara","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.10.019_b0410","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jhep.2014.11.017","article-title":"Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial","volume":"62","author":"Thevenot","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.10.019_b0415","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0140-6736(00)04211-2","article-title":"Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study","volume":"357","author":"Schortgen","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2015.10.019_b0420","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1056\/NEJMoa1204242","article-title":"Hydroxyethyl starch 130\/0.42 versus Ringer\u2019s acetate in severe sepsis","volume":"367","author":"Perner","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2015.10.019_b0425","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"De Backer","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2015.10.019_b0430","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0140-6736(02)08225-9","article-title":"Terlipressin for norepinephrine-resistant septic shock","volume":"359","author":"O\u2019Brien","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2015.10.019_b0435","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00134-003-2094-3","article-title":"Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock","volume":"30","author":"Morelli","year":"2004","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jhep.2015.10.019_b0440","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/cc2945","article-title":"Clinical review: vasopressin and terlipressin in septic shock patients","volume":"9","author":"Delmas","year":"2005","journal-title":"Crit Care"},{"key":"10.1016\/j.jhep.2015.10.019_b0445","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/01.shk.0000136097.42048.bd","article-title":"Terlipressin in catecholamine-resistant septic shock patients","volume":"22","author":"Leone","year":"2004","journal-title":"Shock"},{"key":"10.1016\/j.jhep.2015.10.019_b0450","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hep.25573","article-title":"Adrenocortical dysfunction in liver disease: a systematic review","volume":"55","author":"Fede","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.10.019_b0455","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/jhep.2002.34514","article-title":"The clinical importance of adrenal insufficiency in acute hepatic dysfunction","volume":"36","author":"Harry","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.10.019_b0460","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1097\/01.CCM.0000164541.12106.57","article-title":"Adrenal Pathophysiology Study G. the hepatoadrenal syndrome: a common yet unrecognized clinical condition","volume":"33","author":"Marik","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jhep.2015.10.019_b0465","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/hep.21101","article-title":"Adrenal insufficiency in patients with cirrhosis, severe sepsis and septic shock","volume":"43","author":"Tsai","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.10.019_b0470","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1503\/cmaj.090707","article-title":"Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial","volume":"182","author":"Arabi","year":"2010","journal-title":"CMAJ"},{"key":"10.1016\/j.jhep.2015.10.019_b0475","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/hep.21352","article-title":"Adrenal insufficiency in patients with cirrhosis and septic shock: effect of treatment with hydrocortisone on survival","volume":"44","author":"Fernandez","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.10.019_b0480","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1034\/j.1600-0676.2003.00813.x","article-title":"The effects of supraphysiological doses of corticosteroids in hypotensive liver failure","volume":"23","author":"Harry","year":"2003","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2015.10.019_b0485","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/jama.288.7.862","article-title":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock","volume":"288","author":"Annane","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jhep.2015.10.019_b0490","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature13568","article-title":"Alterations of the human gut microbiome in liver cirrhosis","volume":"513","author":"Qin","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2015.10.019_b0495","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/gut.48.2.206","article-title":"The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis","volume":"48","author":"Wigg","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2015.10.019_b0500","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jhep.2013.01.003","article-title":"Modulation of the fecal bile acid profile by gut microbiota in cirrhosis","volume":"58","author":"Kakiyama","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.10.019_b0505","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jhep.2004.10.019","article-title":"Patients with acute on chronic liver failure display \u201csepsis-like\u201d immune paralysis","volume":"42","author":"Wasmuth","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.10.019_b0510","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/hep.26109","article-title":"Inhibition of mammalian target of rapamycin aggravates the respiratory burst defect of neutrophils from decompensated patients with cirrhosis","volume":"57","author":"Rolas","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.10.019_b0515","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nm.3516","article-title":"Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2","volume":"20","author":"O\u2019Brien","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2015.10.019_b0520","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/hep.25947","article-title":"Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience","volume":"56","author":"Bajaj","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.10.019_b0525","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jhep.2010.06.004","article-title":"Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension","volume":"53","author":"de Franchis","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.10.019_b0530","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2036.2011.04746.x","article-title":"Meta-analysis: antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding - an updated Cochrane review","volume":"34","author":"Chavez-Tapia","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2015.10.019_b0535","first-page":"802","article-title":"Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infection","volume":"24","author":"Pauwels","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.10.019_b0540","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/0016-5085(92)91514-5","article-title":"Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage","volume":"103","author":"Soriano","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.10.019_b0545","doi-asserted-by":"crossref","first-page":"e61666","DOI":"10.1371\/journal.pone.0061666","article-title":"The outcome of prophylactic intravenous cefazolin and ceftriaxone in cirrhotic patients at different clinical stages of disease after endoscopic interventions for acute variceal hemorrhage","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2015.10.019_b0550","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cgh.2008.12.018","article-title":"Role of fluoroquinolones in the primary prophylaxis of spontaneous bacterial peritonitis: meta-analysis","volume":"7","author":"Loomba","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2015.10.019_b0555","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/hep.510250306","article-title":"Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin","volume":"25","author":"Novella","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.10.019_b0560","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/j.gastro.2007.06.065","article-title":"Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis","volume":"133","author":"Fernandez","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.10.019_b0565","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0168-8278(98)80061-5","article-title":"Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial","volume":"29","author":"Grange","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.10.019_b0570","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jhep.2008.01.024","article-title":"Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: a randomized, placebo-controlled study","volume":"48","author":"Terg","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.10.019_b0575","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/MEG.0b013e3283537d61","article-title":"Addition of probiotics to norfloxacin does not improve efficacy in the prevention of spontaneous bacterial peritonitis: a double-blind placebo-controlled randomized-controlled trial","volume":"24","author":"Pande","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2015.10.019_b0580","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1207290","article-title":"Targeted versus universal decolonization to prevent ICU infection","volume":"368","author":"Huang","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2015.10.019_b0585","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1086\/650482","article-title":"Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America","volume":"50","author":"Hooton","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2015.10.019_b0590","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2015.10.019_b0595","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0168-8278(12)60002-6","article-title":"Management of bacterial infections in cirrhosis","volume":"56","author":"Fernandez","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.10.019_b0600","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1002\/hep.23264","article-title":"Severe sepsis in cirrhosis","volume":"50","author":"Gustot","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.10.019_b0605","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jhep.2013.12.019","article-title":"Altered profile of human gut microbiome is associated with cirrhosis and its complications","volume":"60","author":"Bajaj","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.10.019_b0610","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1002\/hep.25931","article-title":"Antimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosis","volume":"56","author":"Arabi","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.10.019_b0615","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1373\/clinchem.2014.221770","article-title":"MALDI-TOF MS for the diagnosis of infectious diseases","volume":"61","author":"Patel","year":"2015","journal-title":"Clin Chem"},{"key":"10.1016\/j.jhep.2015.10.019_b0620","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2217\/fmb.09.70","article-title":"Current status and future perspectives on molecular and serological methods in diagnostic mycology","volume":"4","author":"Lau","year":"2009","journal-title":"Future Microbiol"},{"key":"10.1016\/j.jhep.2015.10.019_b0625","doi-asserted-by":"crossref","first-page":"7661","DOI":"10.3748\/wjg.v11.i48.7661","article-title":"Phagocytic and oxidative burst activity of neutrophils in the end stage of liver cirrhosis","volume":"11","author":"Panasiuk","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2015.10.019_b0630","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/01.mcg.0000248018.08515.f9","article-title":"Infections in patients with end-stage liver disease","volume":"41","author":"Cheruvattath","year":"2007","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2015.10.019_b0635","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1007\/s00134-009-1482-8","article-title":"Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study","volume":"35","author":"Meersseman","year":"2009","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jhep.2015.10.019_b0640","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ijid.2008.10.012","article-title":"Bladder irrigation with amphotericin B and fungal urinary tract infection\u2013systematic review with meta-analysis","volume":"13","author":"Tuon","year":"2009","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jhep.2015.10.019_b0645","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2015.10.019_b0650","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID\u2217 guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients","volume":"18","author":"Cornely","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhep.2015.10.019_b0655","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10096-007-0316-2","article-title":"Candidemia in immunocompromised and immunocompetent critically ill patients: a prospective comparative study","volume":"26","author":"Dimopoulos","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jhep.2015.10.019_b0660","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1053\/j.gastro.2009.08.045","article-title":"An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis","volume":"137","author":"Tripodi","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.10.019_b0665","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/hep.21303","article-title":"Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management","volume":"44","author":"Caldwell","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.10.019_b0670","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/MOH.0b013e32830a9746","article-title":"Thrombocytopenia in liver disease","volume":"15","author":"Giannini","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.jhep.2015.10.019_b0675","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1053\/jhep.2003.50277","article-title":"Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis","volume":"38","author":"Colucci","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.10.019_b0680","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0168-8278(02)00208-8","article-title":"Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study","volume":"37","author":"Montalto","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.10.019_b0685","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1182\/blood.V94.8.2569.420k13_2569_2574","article-title":"Uremic bleeding: closing the circle after 30 years of controversies?","volume":"94","author":"Noris","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2015.10.019_b0690","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1478-3231.2008.01783.x","article-title":"Interlaboratory variability in assessment of the model of end-stage liver disease score","author":"Lisman","year":"2008","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2015.10.019_b0695","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11739-011-0528-4","article-title":"Thrombin generation in plasma from patients with cirrhosis supplemented with normal plasma: considerations on the efficacy of treatment with fresh-frozen plasma","volume":"7","author":"Tripodi","year":"2012","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.jhep.2015.10.019_b0700","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1111\/j.1572-0241.2003.07467.x","article-title":"Role of fresh frozen plasma infusion in correction of coagulopathy of chronic liver disease: a dual phase study","author":"Youssef","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2015.10.019_b0705","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/gut.15.2.99","article-title":"The portal pressure-blood volume relationship in cirrhosis","volume":"15","author":"Zimmon","year":"1974","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2015.10.019_b0710","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/hep.21266","article-title":"Thrombin generation in patients with cirrhosis: the role of platelets","volume":"44","author":"Tripodi","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.10.019_b0715","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/liv.12038","article-title":"Global hemostasis tests in patients with cirrhosis before and after prophylactic platelet transfusion","volume":"33","author":"Tripodi","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2015.10.019_b0720","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1211801","article-title":"Transfusion strategies for acute upper gastrointestinal bleeding","volume":"368","author":"Villanueva","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2015.10.019_b0725","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1046\/j.1440-1746.2003.03144.x","article-title":"Plasma erythropoietin level in patients with cirrhosis and its relationship to the severity of cirrhosis and renal function","volume":"18","author":"Yang","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2015.10.019_b0730","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2036.2004.02088.x","article-title":"Erythropoietin increases platelet reactivity and platelet counts in patients with alcoholic liver cirrhosis: a randomized, double-blind, placebo-controlled study","volume":"20","author":"Homoncik","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2015.10.019_b0735","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1111\/j.1538-7836.2012.04901.x","article-title":"Evidence for an enhanced fibrinolytic capacity in cirrhosis as measured with two different global fibrinolysis tests","volume":"10","author":"Rijken","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jhep.2015.10.019_b0740","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jtcvs.2010.04.043","article-title":"Thromboelastometrically guided transfusion protocol during aortic surgery with circulatory arrest: a prospective, randomized trial","volume":"140","author":"Girdauskas","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jhep.2015.10.019_b0745","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/lt.23668","article-title":"Intraoperative hypercoagulability during liver transplantation as demonstrated by thromboelastography","volume":"19","author":"Krzanicki","year":"2013","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2015.10.019_b0750","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0168-8278(97)80420-5","article-title":"Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thrombelastography","volume":"26","author":"Ben-Ari","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.10.019_b0755","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1007\/s10620-008-0265-3","article-title":"Deep vein thrombosis and pulmonary embolism in cirrhosis patients","volume":"53","author":"Gulley","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2015.10.019_b0760","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.cgh.2010.05.014","article-title":"Liver cirrhosis is associated with venous thromboembolism among hospitalized patients in a nationwide US study","volume":"8","author":"Wu","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2015.10.019_b0765","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/gut.2004.042796","article-title":"Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation","volume":"54","author":"Francoz","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2015.10.019_b0770","doi-asserted-by":"crossref","first-page":"e1251","DOI":"10.1053\/j.gastro.2012.07.018","article-title":"Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis","volume":"143","author":"Villa","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.10.019_b0775","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/lt.22105","article-title":"Portal vein thrombosis and liver transplant survival benefit","volume":"16","author":"Englesbe","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2015.10.019_b0780","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.tmrv.2014.03.002","article-title":"Hemostasis in liver disease: implications of new concepts for perioperative management","volume":"28","author":"Weeder","year":"2014","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.jhep.2015.10.019_b0785","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1111\/j.1538-7836.2012.04824.x","article-title":"Increased anticoagulant response to low-molecular-weight heparin in plasma from patients with advanced cirrhosis","volume":"10","author":"Senzolo","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jhep.2015.10.019_b0790","first-page":"566","article-title":"Complications of thoracentesis in cirrhotic patients with pleural effusion","volume":"93","author":"Castellote","year":"2001","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.jhep.2015.10.019_b0795","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1053\/j.gastro.2010.06.015","article-title":"Reduced mortality rates following elective percutaneous liver biopsies","volume":"139","author":"West","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.10.019_b0800","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.cgh.2010.03.025","article-title":"Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial","volume":"8","author":"Seeff","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2015.10.019_b0805","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jhep.2007.05.001","article-title":"Transjugular liver biopsy\u2013indications, adequacy, quality of specimens, and complications\u2013a systematic review","volume":"47","author":"Kalambokis","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.10.019_b0810","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/bjs.4018","article-title":"Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma","volume":"90","author":"Wei","year":"2003","journal-title":"Br J Surg"},{"key":"10.1016\/j.jhep.2015.10.019_b0815","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/bja\/aeu158","article-title":"Cryoprecipitate therapy","volume":"113","author":"Nascimento","year":"2014","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jhep.2015.10.019_b0820","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/trf.12431","article-title":"Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy","volume":"54","author":"Levy","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.jhep.2015.10.019_b0825","doi-asserted-by":"crossref","first-page":"R76","DOI":"10.1186\/cc12685","article-title":"Management of bleeding and coagulopathy following major trauma: an updated European guideline","volume":"17","author":"Spahn","year":"2013","journal-title":"Crit Care"},{"key":"10.1016\/j.jhep.2015.10.019_b0830","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1398-9995.2009.01973.x","article-title":"Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions","volume":"64","author":"Brozek","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jhep.2015.10.019_b0835","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2482-13-22","article-title":"Prothrombin complex concentrate in the reduction of blood loss during orthotopic liver transplantation: PROTON-trial","volume":"13","author":"Arshad","year":"2013","journal-title":"BMC Surg"},{"key":"10.1016\/j.jhep.2015.10.019_b0840","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/bja\/aes501","article-title":"Long-term safety and efficacy of a pasteurized nanofiltrated prothrombin complex concentrate (Beriplex P\/N): a pharmacovigilance study","volume":"110","author":"Hanke","year":"2013","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jhep.2015.10.019_b0845","doi-asserted-by":"crossref","first-page":"R83","DOI":"10.1186\/cc10078","article-title":"Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy","volume":"15","author":"Schochl","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.jhep.2015.10.019_b0850","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1056\/NEJMoa073255","article-title":"Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C","volume":"357","author":"McHutchison","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2015.10.019_b0855","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1056\/NEJMoa1110709","article-title":"Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia","volume":"367","author":"Afdhal","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2015.10.019_b0860","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1440-1746.2012.07246.x","article-title":"Preoperative use of romiplostim in thrombocytopenic patients with chronic hepatitis C and liver cirrhosis","volume":"28","author":"Moussa","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2015.10.019_b0865","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.ejim.2014.09.006","article-title":"Are adverse drug reaction patterns different between romiplostim and eltrombopag? 2009\u20132013 French PharmacoVigilance assessment","volume":"25","author":"Moulis","year":"2014","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jhep.2015.10.019_b0870","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1097\/00001721-200004001-00017","article-title":"Blood loss in orthotopic liver transplantation: a retrospective analysis of transfusion requirements and the effects of autotransfusion of cell saver blood in 164 consecutive patients","volume":"11","author":"Hendriks","year":"2000","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jhep.2015.10.019_b0875","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1053\/jlts.2001.27086","article-title":"Aprotinin reduces red blood cell transfusion in orthotopic liver transplantation: a prospective, randomized, double-blind study","volume":"7","author":"Findlay","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2015.10.019_b0880","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMoa0802395","article-title":"A comparison of aprotinin and lysine analogues in high-risk cardiac surgery","volume":"358","author":"Fergusson","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2015.10.019_b0885","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2036.2006.02730.x","article-title":"The efficacy and safety of epsilon-aminocaproic acid treatment in patients with cirrhosis and hyperfibrinolysis","volume":"23","author":"Gunawan","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2015.10.019_b0890","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1053\/jhep.2002.31250","article-title":"Hepatic encephalopathy\u2013definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998","volume":"35","author":"Ferenci","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.10.019_b0895","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jhep.2013.10.004","article-title":"Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF)","volume":"60","author":"Cordoba","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.10.019_b0900","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jhep.2014.09.005","article-title":"Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure","volume":"62","author":"Romero-Gomez","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.10.019_b0905","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1478-3231.2009.02030.x","article-title":"Neurophysiological investigations of hepatic encephalopathy: ISHEN practice guidelines","volume":"29","author":"Guerit","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2015.10.019_b0910","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-230X-8-16","article-title":"Liver cirrhosis, other liver diseases, and risk of hospitalisation for intracerebral haemorrhage: a Danish population-based case-control study","volume":"8","author":"Gronbaek","year":"2008","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhep.2015.10.019_b0915","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1365-2036.2007.03394.x","article-title":"Development of a clinical hepatic encephalopathy staging scale","volume":"26","author":"Ortiz","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2015.10.019_b0920","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/ajg.2009.160","article-title":"Performance of the hepatic encephalopathy scoring algorithm in a clinical trial of patients with cirrhosis and severe hepatic encephalopathy","volume":"104","author":"Hassanein","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2015.10.019_b0925","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1365-2036.2012.05038.x","article-title":"Modified-orientation log to assess hepatic encephalopathy","volume":"35","author":"Salam","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2015.10.019_b0930","doi-asserted-by":"crossref","first-page":"526","DOI":"10.7326\/M13-1927","article-title":"The CAM-S: development and validation of a new scoring system for delirium severity in 2 cohorts","volume":"160","author":"Inouye","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2015.10.019_b0935","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2036.2011.04590.x","article-title":"Review article: the design of clinical trials in hepatic encephalopathy\u2013an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement","volume":"33","author":"Bajaj","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2015.10.019_b0940","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(76)92215-7","article-title":"Predicting outcome in individual patients after severe head injury","volume":"1","author":"Jennett","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2015.10.019_b0945","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0168-8278(90)90135-E","article-title":"Branched chain enriched amino acid versus glucose treatment of hepatic encephalopathy. A double-blind study of 65 patients with cirrhosis","volume":"10","author":"Vilstrup","year":"1990","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.10.019_b0950","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/ajg.2011.314","article-title":"Hospital readmissions among patients with decompensated cirrhosis","volume":"107","author":"Volk","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2015.10.019_b0955","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1053\/j.gastro.2009.05.056","article-title":"Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo","volume":"137","author":"Sharma","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.10.019_b0960","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy","volume":"362","author":"Bass","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2015.10.019_b0965","doi-asserted-by":"crossref","first-page":"14934","DOI":"10.3748\/wjg.v20.i40.14934","article-title":"Chronic Liver Failure-Sequential Organ Failure Assessment is better than the Asia-Pacific Association for the Study of Liver criteria for defining acute-on-chronic liver failure and predicting outcome","volume":"20","author":"Dhiman","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2015.10.019_b0970","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0140-6736(05)70239-7","article-title":"Dispelling myths in the treatment of hepatic encephalopathy","volume":"365","author":"Shawcross","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2015.10.019_b0975","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/j.1365-2036.2010.04257.x","article-title":"Predictors of the recurrence of hepatic encephalopathy in lactulose-treated patients","volume":"31","author":"Bajaj","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2015.10.019_b0980","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1136\/gutjnl-2014-308521","article-title":"Randomised controlled trial of lactulose versus rifaximin for prophylaxis of hepatic encephalopathy in patients with acute variceal bleed","volume":"64","author":"Maharshi","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2015.10.019_b0985","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/j.1440-1746.2010.06596.x","article-title":"Prophylaxis of hepatic encephalopathy in acute variceal bleed: a randomized controlled trial of lactulose versus no lactulose","volume":"26","author":"Sharma","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2015.10.019_b0990","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/hep.1840070404","article-title":"Acidifying enemas (lactitol and lactose) vs. nonacidifying enemas (tap water) to treat acute portal-systemic encephalopathy: a double-blind, randomized clinical trial","volume":"7","author":"Uribe","year":"1987","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.10.019_b0995","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1001\/jamainternmed.2014.4746","article-title":"Lactulose vs polyethylene glycol 3350\u2013electrolyte solution for treatment of overt hepatic encephalopathy: the HELP randomized clinical trial","volume":"174","author":"Rahimi","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jhep.2015.10.019_b1000","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11011-013-9383-5","article-title":"Antibiotics for the treatment of hepatic encephalopathy","volume":"28","author":"Patidar","year":"2013","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.jhep.2015.10.019_b1005","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0168-8278(02)00350-1","article-title":"Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial","volume":"38","author":"Mas","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.10.019_b1010","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/ajg.2013.219","article-title":"A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy","volume":"108","author":"Sharma","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2015.10.019_b1015","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1042\/CS20030357","article-title":"Reversal of diuretic-induced hepatic encephalopathy with infusion of albumin but not colloid","volume":"106","author":"Jalan","year":"2004","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jhep.2015.10.019_b1020","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/lt.20236","article-title":"Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study","volume":"10","author":"Sen","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2015.10.019_b1025","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/hep.21930","article-title":"Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis","volume":"46","author":"Hassanein","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.10.019_b1030","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/hep.26185","article-title":"Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial","volume":"57","author":"Banares","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.10.019_b1035","doi-asserted-by":"crossref","first-page":"R8","DOI":"10.1186\/cc7697","article-title":"Albumin dialysis improves hepatic encephalopathy and decreases circulating phenolic aromatic amino acids in patients with alcoholic hepatitis and severe liver failure","volume":"13","author":"Pares","year":"2009","journal-title":"Crit Care"},{"key":"10.1016\/j.jhep.2015.10.019_b1040","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1053\/jhep.2002.36130","article-title":"Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study","volume":"36","author":"Heemann","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.10.019_b1045","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/lv.2000.6355","article-title":"Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial","volume":"6","author":"Mitzner","year":"2000","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2015.10.019_b1050","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0168-8278(02)00334-3","article-title":"Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis","volume":"38","author":"Jalan","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.10.019_b1055","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0168-8278(98)80237-7","article-title":"Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study","volume":"28","author":"Stauch","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.10.019_b1060","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1097\/CCM.0b013e31828a437d","article-title":"Early goal-directed sedation versus standard sedation in mechanically ventilated critically ill patients: a pilot study\u2217","volume":"41","author":"Shehabi","year":"2013","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jhep.2015.10.019_b1065","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jcrc.2013.07.062","article-title":"Dexmedetomidine preserves attention\/calculation when used for cooperative and short-term intensive care unit sedation","volume":"28","author":"Goodwin","year":"2013","journal-title":"J Crit Care"},{"key":"10.1016\/j.jhep.2015.10.019_b1070","doi-asserted-by":"crossref","first-page":"e82913","DOI":"10.1371\/journal.pone.0082913","article-title":"Dexmedetomidine as a sedative agent in critically ill patients: a meta-analysis of randomized controlled trials","volume":"8","author":"Pasin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2015.10.019_b1075","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s40263-013-0106-6","article-title":"Dexmedetomidine for the treatment of alcohol withdrawal syndrome: rationale and current status of research","volume":"27","author":"Muzyk","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jhep.2015.10.019_b1080","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1097\/CCM.0000000000000328","article-title":"A comparison of severe hemodynamic disturbances between dexmedetomidine and propofol for sedation in neurocritical care patients","volume":"42","author":"Erdman","year":"2014","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jhep.2015.10.019_b1085","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1182\/blood-2010-02-261891","article-title":"Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences","volume":"116","author":"Lisman","year":"2010","journal-title":"Blood"}],"updated-by":[{"DOI":"10.1016\/j.jhep.2016.05.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000}}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827815007187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827815007187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T05:29:41Z","timestamp":1718170181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827815007187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":217,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0168827815007187"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2015.10.019","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of the critically ill patient with cirrhosis: A multidisciplinary perspective","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2015.10.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}